Medicrea receives FDA clearance for new spine device: 5 things to know

Mackenzie Garrity -   Print  |

Medicrea received FDA clearance for its IB3D range of 3-D printed titanium interbody devices and introduced AdapTEK.

Here are five things to know:

 

1. AdapTEK allows physicians to create a range of interbody devices to individual specifications that are then produced by Medicrea.

 

2. Medicrea's AdapTek technology leverages a surgeon's clinical insight to design implants with a range of different footprints, lordotic angles, heights, lateral windows and endplate surfaces.

 

3. AdapTek also uses the company's HexaLock structure design to enhance bone implant interaction during fusions.

 

4. Medicrea President and CEO Denys Sournac said, "With the FDA clearance of our 3-D printed titanium interbodies, we are able to approach a large segment of the spine market, where we were not previously present. This initial FDA clearance will support future strategic IB3D FDA clearances."

 

5. With more than 30 FDA approved spinal implant technologies, Medicrea's devices have been used in more than 150,000 spinal surgeries.

 

More articles on devices and implants:
Global bioactive fillings market to experience 9.2% CAGR until 2023: 6 takeaways
Medtronic reports 4% Q2 revenue drop due to hurricanes, divestiture to Cardinal Health: 5 key notes
Interventional spine devices market to experience 10.5% CAGR through 2021: 4 highlights

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers